Shweta Pandya

Statistics

Publications

Citations

437

H-Index

Active since

2014

Affiliations

Regulus Therapeutics (United States)(Current)

Shweta Pandya is an author at Regulus Therapeutics (United States) specializing in microrna therapeutics, microrna-mediated regulation, and pharmacology.

Publications per year

2014–2017

Publications

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways

Ivan G. Gomez, Deidre A. MacKenna, Bryce G. Johnson et al. · Journal of Clinical Investigation · 2014 · 407 citations · Full text

Medicine, Molecular Medicine, Nephrology +17

Polysome shift assay for direct measurement of miRNA inhibition by anti-miRNA drugs

John R. Androsavich, Daniel J. Sobczynski, Xueqing Liu et al. · Nucleic Acids Research · 2015 · 18 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody

Pamela Farrell, Jennifer Matuszkiewicz, Deepika Balakrishna et al. · Molecular Cancer Therapeutics · 2017 · 12 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3